Skip to main content
Fig. 4 | Allergy, Asthma & Clinical Immunology

Fig. 4

From: Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi

Fig. 4

Clinical course of the patient from the time of development of thrombi in both pulmonary arteries to the time of last examination. Eo eosinophil, FFP formoterol fluticasone combination, FP fluticasone propionate, HFA hydrofluoroalkane, ICS inhaled corticosteroid, IVIG intravenous immunoglobulin, MPO-ANCA myeloperoxidase-anti-neutrophil cytoplasmic antibody, MTX methotrexate, PSL prednisolone, WBC white blood cell count

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us